References

No references inside the corpus for this window.

Cited by

• 1991Product Quality: An Investigation into the Concept and How It Is Perceived by Consumers173 cited
• 2011The differential effects of public R&D support on firm R&D: Theory and evidence from multi-country data161 cited
• 2000Building models for marketing decisions:157 cited
• 1991Pricing, Patent Loss and the Market For Pharmaceuticals157 cited
• 1975Optimal marketing behavior in oligopoly142 cited
• 2017The persistency and volatility of the firm R&D investment: Revisited from the perspective of technological capability111 cited
• 2023Dynamic blockchain adoption for freshness-keeping in the fresh agricultural product supply chain109 cited
• 2006Is philanthropy strategic? An analysis of the management of charitable giving in large UK companies109 cited
• 1990The Concentration-Margins Relationship Reconsidered108 cited
• 1998Persuasive Advertising and Product Differentiation97 cited
• 2019Optimal joint dynamic pricing, advertising and inventory control model for perishable items with psychic stock effect86 cited
• 2011Competition in Health Care Markets11We wish to thank participants at the Handbook of Health Economics meeting in Lisbon, Portugal, Pedro Pita Barros, Rein Halbersman, and Cory Capps for helpful comments and suggestions. Misja Mikkers, Rein Halbersma, and Ramsis Croes of the Netherlands Healthcare Authority graciously provided data on hospital and insurance market structure in the Netherlands. David Emmons kindly provided aggregates of the American Medical Association's calculations of health insurance market structure. Leemore Dafny was kind enough to share her measures of market concentration for the large employer segment of the US health insurance market. All opinions expressed here and any errors are the sole responsibility of the authors. No endorsement or approval by any other individuals or institutions is implied or should be inferred.